Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Gralla

Showing results (91-100 of 326) with videos related to

Pageof 33
Sort By:
Future Oncology (London, England)|August 21, 2015
Slow-release granisetron (APF530) versus palonosetron for chemotherapy-induced nausea/vomiting: analysis by American Society of Clinical Oncology emetogenicity criteriaHarry Raftopoulos, Ralph Boccia, William Cooper, et al.
Transplantation Proceedings|June 9, 2018
Effect of Sirolimus on Native Total Kidney Volume After Transplantation in Patients with Autosomal Dominant Polycystic Kidney Disease: A Randomized Controlled Pilot StudyS Davis, J Gralla, L Chan, et al.
Praxis|January 21, 2010
[What is your diagnosis? Idiopathic hypertrophic pachymeningitis]L Chilver-Stainer, B Keserü, M Arnold, et al.
AJNR. American Journal of Neuroradiology|November 22, 2008
CT radiation dose for computer-assisted endoscopic sinus surgery: dose survey and determination of dose-reduction limitsC B Nauer, A Eichenberger, P Dubach, et al.
Oncology|June 1, 1996
Cisplatin and emesis: aspects of treatment and a new trial for delayed emesis using oral dexamethasone plus ondansetron beginning at 16 hours after cisplatinR J Gralla, C Rittenberg, M Peralta, et al.
Annals of Neurology|August 1, 1982
Neurotoxicity of the pyrimidine synthesis inhibitor N-phosphonoacetyl-L-aspartateR G Wiley, R J Gralla, E S Casper, et al.
BMJ Supportive & Palliative Care|February 8, 2017
Key issues affecting quality of life and patient-reported outcomes in prostate cancer: an analysis conducted in 2128 patients with initial psychometric assessment of the prostate cancer symptom scale (PCSS)Pavlos Msaouel, Richard J Gralla, Randy A Jones, et al.
Cancer Treatment Reports|July 1, 1981
Phase II evaluation of chlorozotocin in patients with malignant melanomaA N Houghton, F J Camacho, R J Gralla, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|July 1, 1994
Quality of life during clinical trials: conceptual model for the Lung Cancer Symptom Scale (LCSS)P J Hollen, R J Gralla, M G Kris, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|June 18, 1998
Methodology of antiemetic trials: response assessment, evaluation of new agents and definition of chemotherapy emetogenicityP J Hesketh, R J Gralla, A du Bois, et al.
Pageof 33

Showing results (91-100 of 326) with videos related to

Sort By:
Pageof 33
Future Oncology (London, England)|August 21, 2015
Slow-release granisetron (APF530) versus palonosetron for chemotherapy-induced nausea/vomiting: analysis by American Society of Clinical Oncology emetogenicity criteriaHarry Raftopoulos, Ralph Boccia, William Cooper, et al.
Transplantation Proceedings|June 9, 2018
Effect of Sirolimus on Native Total Kidney Volume After Transplantation in Patients with Autosomal Dominant Polycystic Kidney Disease: A Randomized Controlled Pilot StudyS Davis, J Gralla, L Chan, et al.
Praxis|January 21, 2010
[What is your diagnosis? Idiopathic hypertrophic pachymeningitis]L Chilver-Stainer, B Keserü, M Arnold, et al.
AJNR. American Journal of Neuroradiology|November 22, 2008
CT radiation dose for computer-assisted endoscopic sinus surgery: dose survey and determination of dose-reduction limitsC B Nauer, A Eichenberger, P Dubach, et al.
Oncology|June 1, 1996
Cisplatin and emesis: aspects of treatment and a new trial for delayed emesis using oral dexamethasone plus ondansetron beginning at 16 hours after cisplatinR J Gralla, C Rittenberg, M Peralta, et al.
Annals of Neurology|August 1, 1982
Neurotoxicity of the pyrimidine synthesis inhibitor N-phosphonoacetyl-L-aspartateR G Wiley, R J Gralla, E S Casper, et al.
BMJ Supportive & Palliative Care|February 8, 2017
Key issues affecting quality of life and patient-reported outcomes in prostate cancer: an analysis conducted in 2128 patients with initial psychometric assessment of the prostate cancer symptom scale (PCSS)Pavlos Msaouel, Richard J Gralla, Randy A Jones, et al.
Cancer Treatment Reports|July 1, 1981
Phase II evaluation of chlorozotocin in patients with malignant melanomaA N Houghton, F J Camacho, R J Gralla, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|July 1, 1994
Quality of life during clinical trials: conceptual model for the Lung Cancer Symptom Scale (LCSS)P J Hollen, R J Gralla, M G Kris, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|June 18, 1998
Methodology of antiemetic trials: response assessment, evaluation of new agents and definition of chemotherapy emetogenicityP J Hesketh, R J Gralla, A du Bois, et al.
Pageof 33